aluates Reports

$ 0.0

Automative

Global Uterine Cancer Therapies and Diagnostic Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-25V13269

Global Uterine Cancer Therapies and Diagnostic Market Research Report 2023

BUY CHAPTERS

Global Uterine Cancer Therapies and Diagnostic Market Insights, Forecast to 2030

Code: QYRE-Auto-25V13269

Report

December 2024

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ariad Pharmaceuticals

Merck

AbbVie

Uterine Cancer Therapies and Diagnostic Market Size

The global Uterine Cancer Therapies and Diagnostic market is projected to grow from US$ 21650 million in 2024 to US$ 28120 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.

Uterine Cancer Therapies and Diagnostic Market

Uterine cancer is a common form of cancer of the female reproductive system that initiates in the lining of the uterus.

Market Analysis and Insights: Global Uterine Cancer Therapies and Diagnostic Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Uterine Cancer Therapies and Diagnostic market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Uterine Cancer Therapies and Diagnostic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Uterine Cancer Therapies and Diagnostic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Uterine Cancer Therapies and Diagnostic revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Uterine Cancer Therapies and Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Uterine Cancer Therapies and Diagnostic revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Uterine Cancer Therapies and Diagnostic Market Report

Report Metric	Details
Report Name	Uterine Cancer Therapies and Diagnostic Market
Accounted market size in 2024	US$ 21650 million
Forecasted market size in 2030	US$ 28120 million
CAGR	4.5
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Uterine Sarcomas Endometrial Carcinomas
Segment by Application	Hospitals Ambulatory Surgical Centers Specialty Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ariad Pharmaceuticals, Merck, AbbVie, BD
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Uterine Cancer Therapies and Diagnostic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Uterine Cancer Therapies and Diagnostic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Uterine Cancer Therapies and Diagnostic revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Uterine Cancer Therapies and Diagnostic Market growing?

Ans: The Uterine Cancer Therapies and Diagnostic Market witnessing a CAGR of 4.5 during the forecast period 2025-2030.

What is the Uterine Cancer Therapies and Diagnostic Market size in 2030?

Ans: The Uterine Cancer Therapies and Diagnostic Market size in 2030 will be US$ 28120 million.

Who are the main players in the Uterine Cancer Therapies and Diagnostic Market report?

Ans: The main players in the Uterine Cancer Therapies and Diagnostic Market are Ariad Pharmaceuticals, Merck, AbbVie, BD

What are the Application segmentation covered in the Uterine Cancer Therapies and Diagnostic Market report?

Ans: The Applications covered in the Uterine Cancer Therapies and Diagnostic Market report are Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others

What are the Type segmentation covered in the Uterine Cancer Therapies and Diagnostic Market report?

Ans: The Types covered in the Uterine Cancer Therapies and Diagnostic Market report are Uterine Sarcomas, Endometrial Carcinomas

Recommended Reports

Cancer Diagnostics

Cancer Therapeutics

Women's Health

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Uterine Sarcomas

1.2.3 Endometrial Carcinomas

1.3 Market by Application

1.3.1 Global Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Specialty Clinics

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Uterine Cancer Therapies and Diagnostic Market Perspective (2019-2030)

2.2 Global Uterine Cancer Therapies and Diagnostic Growth Trends by Region

2.2.1 Uterine Cancer Therapies and Diagnostic Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Uterine Cancer Therapies and Diagnostic Historic Market Size by Region (2019-2024)

2.2.3 Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Region (2025-2030)

2.3 Uterine Cancer Therapies and Diagnostic Market Dynamics

2.3.1 Uterine Cancer Therapies and Diagnostic Industry Trends

2.3.2 Uterine Cancer Therapies and Diagnostic Market Drivers

2.3.3 Uterine Cancer Therapies and Diagnostic Market Challenges

2.3.4 Uterine Cancer Therapies and Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Uterine Cancer Therapies and Diagnostic by Players

3.1.1 Global Uterine Cancer Therapies and Diagnostic Revenue by Players (2019-2024)

3.1.2 Global Uterine Cancer Therapies and Diagnostic Revenue Market Share by Players (2019-2024)

3.2 Global Uterine Cancer Therapies and Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Uterine Cancer Therapies and Diagnostic, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Uterine Cancer Therapies and Diagnostic Market Concentration Ratio

3.4.1 Global Uterine Cancer Therapies and Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Uterine Cancer Therapies and Diagnostic Revenue in 2023

3.5 Global Key Players of Uterine Cancer Therapies and Diagnostic Head office and Area Served

3.6 Global Key Players of Uterine Cancer Therapies and Diagnostic, Product and Application

3.7 Global Key Players of Uterine Cancer Therapies and Diagnostic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Uterine Cancer Therapies and Diagnostic Breakdown Data by Type

4.1 Global Uterine Cancer Therapies and Diagnostic Historic Market Size by Type (2019-2024)

4.2 Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Type (2025-2030)

5 Uterine Cancer Therapies and Diagnostic Breakdown Data by Application

5.1 Global Uterine Cancer Therapies and Diagnostic Historic Market Size by Application (2019-2024)

5.2 Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Uterine Cancer Therapies and Diagnostic Market Size (2019-2030)

6.2 North America Uterine Cancer Therapies and Diagnostic Market Size by Type

6.2.1 North America Uterine Cancer Therapies and Diagnostic Market Size by Type (2019-2024)

6.2.2 North America Uterine Cancer Therapies and Diagnostic Market Size by Type (2025-2030)

6.2.3 North America Uterine Cancer Therapies and Diagnostic Market Share by Type (2019-2030)

6.3 North America Uterine Cancer Therapies and Diagnostic Market Size by Application

6.3.1 North America Uterine Cancer Therapies and Diagnostic Market Size by Application (2019-2024)

6.3.2 North America Uterine Cancer Therapies and Diagnostic Market Size by Application (2025-2030)

6.3.3 North America Uterine Cancer Therapies and Diagnostic Market Share by Application (2019-2030)

6.4 North America Uterine Cancer Therapies and Diagnostic Market Size by Country

6.4.1 North America Uterine Cancer Therapies and Diagnostic Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Uterine Cancer Therapies and Diagnostic Market Size by Country (2019-2024)

6.4.3 North America Uterine Cancer Therapies and Diagnostic Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Uterine Cancer Therapies and Diagnostic Market Size (2019-2030)

7.2 Europe Uterine Cancer Therapies and Diagnostic Market Size by Type

7.2.1 Europe Uterine Cancer Therapies and Diagnostic Market Size by Type (2019-2024)

7.2.2 Europe Uterine Cancer Therapies and Diagnostic Market Size by Type (2025-2030)

7.2.3 Europe Uterine Cancer Therapies and Diagnostic Market Share by Type (2019-2030)

7.3 Europe Uterine Cancer Therapies and Diagnostic Market Size by Application

7.3.1 Europe Uterine Cancer Therapies and Diagnostic Market Size by Application (2019-2024)

7.3.2 Europe Uterine Cancer Therapies and Diagnostic Market Size by Application (2025-2030)

7.3.3 Europe Uterine Cancer Therapies and Diagnostic Market Share by Application (2019-2030)

7.4 Europe Uterine Cancer Therapies and Diagnostic Market Size by Country

7.4.1 Europe Uterine Cancer Therapies and Diagnostic Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Uterine Cancer Therapies and Diagnostic Market Size by Country (2019-2024)

7.4.3 Europe Uterine Cancer Therapies and Diagnostic Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Uterine Cancer Therapies and Diagnostic Market Size (2019-2030)

8.2 China Uterine Cancer Therapies and Diagnostic Market Size by Type

8.2.1 China Uterine Cancer Therapies and Diagnostic Market Size by Type (2019-2024)

8.2.2 China Uterine Cancer Therapies and Diagnostic Market Size by Type (2025-2030)

8.2.3 China Uterine Cancer Therapies and Diagnostic Market Share by Type (2019-2030)

8.3 China Uterine Cancer Therapies and Diagnostic Market Size by Application

8.3.1 China Uterine Cancer Therapies and Diagnostic Market Size by Application (2019-2024)

8.3.2 China Uterine Cancer Therapies and Diagnostic Market Size by Application (2025-2030)

8.3.3 China Uterine Cancer Therapies and Diagnostic Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Uterine Cancer Therapies and Diagnostic Market Size (2019-2030)

9.2 Asia Uterine Cancer Therapies and Diagnostic Market Size by Type

9.2.1 Asia Uterine Cancer Therapies and Diagnostic Market Size by Type (2019-2024)

9.2.2 Asia Uterine Cancer Therapies and Diagnostic Market Size by Type (2025-2030)

9.2.3 Asia Uterine Cancer Therapies and Diagnostic Market Share by Type (2019-2030)

9.3 Asia Uterine Cancer Therapies and Diagnostic Market Size by Application

9.3.1 Asia Uterine Cancer Therapies and Diagnostic Market Size by Application (2019-2024)

9.3.2 Asia Uterine Cancer Therapies and Diagnostic Market Size by Application (2025-2030)

9.3.3 Asia Uterine Cancer Therapies and Diagnostic Market Share by Application (2019-2030)

9.4 Asia Uterine Cancer Therapies and Diagnostic Market Size by Region

9.4.1 Asia Uterine Cancer Therapies and Diagnostic Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Uterine Cancer Therapies and Diagnostic Market Size by Region (2019-2024)

9.4.3 Asia Uterine Cancer Therapies and Diagnostic Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Type

10.2.1 Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Application

10.3.1 Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country

10.4.1 Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Ariad Pharmaceuticals

11.1.1 Ariad Pharmaceuticals Company Details

11.1.2 Ariad Pharmaceuticals Business Overview

11.1.3 Ariad Pharmaceuticals Uterine Cancer Therapies and Diagnostic Introduction

11.1.4 Ariad Pharmaceuticals Revenue in Uterine Cancer Therapies and Diagnostic Business (2019-2024)

11.1.5 Ariad Pharmaceuticals Recent Developments

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Uterine Cancer Therapies and Diagnostic Introduction

11.2.4 Merck Revenue in Uterine Cancer Therapies and Diagnostic Business (2019-2024)

11.2.5 Merck Recent Developments

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Uterine Cancer Therapies and Diagnostic Introduction

11.3.4 AbbVie Revenue in Uterine Cancer Therapies and Diagnostic Business (2019-2024)

11.3.5 AbbVie Recent Developments

11.4 BD

11.4.1 BD Company Details

11.4.2 BD Business Overview

11.4.3 BD Uterine Cancer Therapies and Diagnostic Introduction

11.4.4 BD Revenue in Uterine Cancer Therapies and Diagnostic Business (2019-2024)

11.4.5 BD Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Ariad Pharmaceuticals

Merck

AbbVie

List of Tables

Table 1. Global Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Uterine Sarcomas

Table 3. Key Players of Endometrial Carcinomas

Table 4. Global Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Uterine Cancer Therapies and Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Uterine Cancer Therapies and Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Uterine Cancer Therapies and Diagnostic Market Share by Region (2019-2024)

Table 8. Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Uterine Cancer Therapies and Diagnostic Market Share by Region (2025-2030)

Table 10. Uterine Cancer Therapies and Diagnostic Market Trends

Table 11. Uterine Cancer Therapies and Diagnostic Market Drivers

Table 12. Uterine Cancer Therapies and Diagnostic Market Challenges

Table 13. Uterine Cancer Therapies and Diagnostic Market Restraints

Table 14. Global Uterine Cancer Therapies and Diagnostic Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Uterine Cancer Therapies and Diagnostic Revenue Share by Players (2019-2024)

Table 16. Global Top Uterine Cancer Therapies and Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Cancer Therapies and Diagnostic as of 2023)

Table 17. Global Uterine Cancer Therapies and Diagnostic Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Uterine Cancer Therapies and Diagnostic Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Uterine Cancer Therapies and Diagnostic, Headquarters and Area Served

Table 20. Global Key Players of Uterine Cancer Therapies and Diagnostic, Product and Application

Table 21. Global Key Players of Uterine Cancer Therapies and Diagnostic, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Uterine Cancer Therapies and Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Uterine Cancer Therapies and Diagnostic Revenue Market Share by Type (2019-2024)

Table 25. Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Uterine Cancer Therapies and Diagnostic Revenue Market Share by Type (2025-2030)

Table 27. Global Uterine Cancer Therapies and Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Uterine Cancer Therapies and Diagnostic Revenue Share by Application (2019-2024)

Table 29. Global Uterine Cancer Therapies and Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Uterine Cancer Therapies and Diagnostic Revenue Share by Application (2025-2030)

Table 31. North America Uterine Cancer Therapies and Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Uterine Cancer Therapies and Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Uterine Cancer Therapies and Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Uterine Cancer Therapies and Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Uterine Cancer Therapies and Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Uterine Cancer Therapies and Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Uterine Cancer Therapies and Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Uterine Cancer Therapies and Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Uterine Cancer Therapies and Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Uterine Cancer Therapies and Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Uterine Cancer Therapies and Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Uterine Cancer Therapies and Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Uterine Cancer Therapies and Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Uterine Cancer Therapies and Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Uterine Cancer Therapies and Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Uterine Cancer Therapies and Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Uterine Cancer Therapies and Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Uterine Cancer Therapies and Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Uterine Cancer Therapies and Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Uterine Cancer Therapies and Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Uterine Cancer Therapies and Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Uterine Cancer Therapies and Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Uterine Cancer Therapies and Diagnostic Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Uterine Cancer Therapies and Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Uterine Cancer Therapies and Diagnostic Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 63. Ariad Pharmaceuticals Company Details

Table 64. Ariad Pharmaceuticals Business Overview

Table 65. Ariad Pharmaceuticals Uterine Cancer Therapies and Diagnostic Product

Table 66. Ariad Pharmaceuticals Revenue in Uterine Cancer Therapies and Diagnostic Business (2019-2024) & (US$ Million)

Table 67. Ariad Pharmaceuticals Recent Developments

Table 68. Merck Company Details

Table 69. Merck Business Overview

Table 70. Merck Uterine Cancer Therapies and Diagnostic Product

Table 71. Merck Revenue in Uterine Cancer Therapies and Diagnostic Business (2019-2024) & (US$ Million)

Table 72. Merck Recent Developments

Table 73. AbbVie Company Details

Table 74. AbbVie Business Overview

Table 75. AbbVie Uterine Cancer Therapies and Diagnostic Product

Table 76. AbbVie Revenue in Uterine Cancer Therapies and Diagnostic Business (2019-2024) & (US$ Million)

Table 77. AbbVie Recent Developments

Table 78. BD Company Details

Table 79. BD Business Overview

Table 80. BD Uterine Cancer Therapies and Diagnostic Product

Table 81. BD Revenue in Uterine Cancer Therapies and Diagnostic Business (2019-2024) & (US$ Million)

Table 82. BD Recent Developments

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Uterine Cancer Therapies and Diagnostic Market Share by Type: 2023 VS 2030

Figure 3. Uterine Sarcomas Features

Figure 4. Endometrial Carcinomas Features

Figure 5. Global Uterine Cancer Therapies and Diagnostic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Uterine Cancer Therapies and Diagnostic Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Ambulatory Surgical Centers Case Studies

Figure 9. Specialty Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Uterine Cancer Therapies and Diagnostic Report Years Considered

Figure 12. Global Uterine Cancer Therapies and Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Uterine Cancer Therapies and Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Uterine Cancer Therapies and Diagnostic Market Share by Region: 2023 VS 2030

Figure 15. Global Uterine Cancer Therapies and Diagnostic Market Share by Players in 2023

Figure 16. Global Top Uterine Cancer Therapies and Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Cancer Therapies and Diagnostic as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Uterine Cancer Therapies and Diagnostic Revenue in 2023

Figure 18. North America Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Uterine Cancer Therapies and Diagnostic Market Share by Type (2019-2030)

Figure 20. North America Uterine Cancer Therapies and Diagnostic Market Share by Application (2019-2030)

Figure 21. North America Uterine Cancer Therapies and Diagnostic Market Share by Country (2019-2030)

Figure 22. United States Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Uterine Cancer Therapies and Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Uterine Cancer Therapies and Diagnostic Market Share by Type (2019-2030)

Figure 26. Europe Uterine Cancer Therapies and Diagnostic Market Share by Application (2019-2030)

Figure 27. Europe Uterine Cancer Therapies and Diagnostic Market Share by Country (2019-2030)

Figure 28. Germany Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Uterine Cancer Therapies and Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Uterine Cancer Therapies and Diagnostic Market Share by Type (2019-2030)

Figure 36. China Uterine Cancer Therapies and Diagnostic Market Share by Application (2019-2030)

Figure 37. Asia Uterine Cancer Therapies and Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Uterine Cancer Therapies and Diagnostic Market Share by Type (2019-2030)

Figure 39. Asia Uterine Cancer Therapies and Diagnostic Market Share by Application (2019-2030)

Figure 40. Asia Uterine Cancer Therapies and Diagnostic Market Share by Region (2019-2030)

Figure 41. Japan Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Uterine Cancer Therapies and Diagnostic Market Share by Country (2019-2030)

Figure 51. Brazil Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Uterine Cancer Therapies and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Ariad Pharmaceuticals Revenue Growth Rate in Uterine Cancer Therapies and Diagnostic Business (2019-2024)

Figure 58. Merck Revenue Growth Rate in Uterine Cancer Therapies and Diagnostic Business (2019-2024)

Figure 59. AbbVie Revenue Growth Rate in Uterine Cancer Therapies and Diagnostic Business (2019-2024)

Figure 60. BD Revenue Growth Rate in Uterine Cancer Therapies and Diagnostic Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Uterine Cancer Diagnostic Testing Market

Global Gynecological Cancers Therapeutics Market Insights Forecast to 2030

Global Uterine Fibroids Treatment Market Insights Forecast to 2030

Global Breast Cancer Diagnostic and Drug Technologies Market Insights Forecast to 2030

Global Ovarian Cancer Diagnostics Technologies Market Insights Forecast to 2030

Global Uterine Diseases Therapeutics Market Research Report 2024

Global Uterine Sarcoma Treatment Market Insights Forecast to 2030

Global Breast Cancer Diagnostic Technologies Market Insights Forecast to 2030

Global Appendiceal Cancer Treatment Market Insights Forecast to 2030

Global Fallopian Tube Cancer Therapeutics Market Insights Forecast to 2030

Global Women s Health Diagnostics Market Insights Forecast to 2030

Global Women Health Diagnostics Market Insights Forecast to 2030

Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030

Global Uterine Catheter Market Insights Forecast to 2030

Global Robotic Surgery Systemsfor Endometrial Cancer Market Research Report 2025

Global Ovarian Cancer Diagnostics and Therapeutics Market Insights Forecast to 2030

Uterine Fibroid Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gynaecological Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Molecular Diagnosis of Endometrial Carcinoma Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions